Skip to main navigation Skip to search Skip to main content

A Phase 3 Open Label Study to Evaluate the Long-term Safety and Tolerability of ALKS 8700 in Adults with Relapsing Remitting Multiple Sclerosis

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date05/30/17 → 05/29/22

Funding

  • Alkermes Incorporated: $49,669.97